RAB27B inhibits proliferation and promotes apoptosis of leukemic cells via 3-Hydroxy butyrate dehydrogenase 2 (BDH2)

References

• Dinmohamed AG, Visser O, van Norden Y, et al. Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989-2012. Leukemia. 2016;30:24–31.
   PubMed Web of Science ®Google Scholar
• Seval GC, Ozcan M. Treatment of acute myeloid leukemia in adolescent and young adult patients. J Clin Med. 2015;4:441–459.
   PubMed Web of Science ®Google Scholar
• Wilhelmson AS, Porse BT. CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance. Br J Haematol. 2020;190:495–507.
   PubMed Web of Science ®Google Scholar
• Kulsoom B, Shamsi TS, Ahmed N, et al. Recent advances in diagnostic and prognostic aspects of acute myeloid leukaemia. J Pak Med Assoc. 2017;67:1580–1587.
   PubMed Web of Science ®Google Scholar
• Schlenk RF, Dohner H. Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2013;2013:324–330.
   PubMedGoogle Scholar
• Hong Y, Tian X, Wang M, et al. Bioinformatics-based identification of SPNS3 (Spinster homolog 3) as a prognostic biomarker of apoptosis resistance in acute myeloid leukemia. Bioengineered. 2021;12:7837–7848.
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng F. Circular RNA circCRKL inhibits the proliferation of acute myeloid leukemia cells via the miR-196a-5p/miR-196b-5p/p27 axis. Bioengineered. 2021;12:7704–7713.
   PubMed Web of Science ®Google Scholar
• Tian H, Qiang T, Wang J, et al. Simvastatin regulates the proliferation, apoptosis, migration and invasion of human acute myeloid leukemia cells via miR-19a-3p/HIF-1α axis. Bioengineered. 2021;12:11898–11908.
   PubMed Web of Science ®Google Scholar
• Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev. 2011;91:119–149.
   PubMed Web of Science ®Google Scholar
• Fukuda M. Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci. 2008;65:2801–2813.
   PubMed Web of Science ®Google Scholar
• Li J, Jin Q, Huang F, et al. Effects of Rab27A and Rab27B on invasion, proliferation, apoptosis, and chemoresistance in human pancreatic cancer cells. Pancreas. 2017;46:1173–1179.
   PubMed Web of Science ®Google Scholar
• Ho JR, Chapeaublanc E, Kirkwood L, et al. Deregulation of Rab and Rab effector genes in bladder cancer. PLoS One. 2012;7:e39469.
   PubMed Web of Science ®Google Scholar
• Peng D, Wang H, Li L, et al. miR-34c-5p promotes eradication of acute myeloid leukemia stem cells by inducing senescence through selective RAB27B targeting to inhibit exosome shedding. Leukemia. 2018;32:1180–1188.
   PubMed Web of Science ®Google Scholar
• Guo K, Lukacik P, Papagrigoriou E, et al. Characterization of human DHRS6, an orphan short chain dehydrogenase/reductase enzyme: a novel, cytosolic type 2 R-beta-hydroxybutyrate dehydrogenase. J Biol Chem. 2006;281:10291–10297.
   PubMed Web of Science ®Google Scholar
• Liu JZ, Hu YL, Feng Y, et al. BDH2 triggers ROS-induced cell death and autophagy by promoting Nrf2 ubiquitination in gastric cancer. J Exp Clin Cancer Res. 2020;39:123.
   PubMed Web of Science ®Google Scholar
• Yang WC, Tsai WC, Lin PM, et al. Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia. J Biomed Sci. 2013;20:58.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–w102.
   PubMed Web of Science ®Google Scholar
• Huang D, Bian G, Pan Y, et al. MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells. Cancer Cell Int. 2017;17:32.
   PubMed Web of Science ®Google Scholar
• Nishioka S, Wu PH, Yakabe T, et al. Rab27b contributes to radioresistance and exerts a paracrine effect via epiregulin in glioblastoma. Neurooncol Adv. 2020;2:vdaa091.
   PubMedGoogle Scholar
• Nagata K, Itoh H, Katada T, et al. Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein. J Biol Chem. 1989;264:17000–17005.
   PubMedGoogle Scholar
• Hendrix A, Maynard D, Pauwels P, et al. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst. 2010;102:866–880.
   PubMedGoogle Scholar
• Ostenfeld MS, Jeppesen DK, Laurberg JR, et al. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014;74:5758–5771.
   PubMed Web of Science ®Google Scholar
• DiNardo CD, Cortes JE. Mutations in AML: prognostic and therapeutic implications. Hematology Am Soc Hematol Educ Program. 2016;2016:348–355.
   PubMedGoogle Scholar
• Feng Y, Hu S, Li L, et al. LncRNA NR-104098 inhibits AML proliferation and induces differentiation through repressing EZH2 transcription by interacting with E2F1. Front Cell Dev Biol. 2020;8:142.
   PubMed Web of Science ®Google Scholar
• Menendez-Gonzalez JB, Sinnadurai S, Gibbs A, et al. Inhibition of GATA2 restrains cell proliferation and enhances apoptosis and chemotherapy mediated apoptosis in human GATA2 overexpressing AML cells. Sci Rep. 2019;9:12212.
   PubMed Web of Science ®Google Scholar
• Baakhlagh S, Kashani B, Zandi Z, et al. Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation. Int Immunopharmacol. 2021;90:107202.
   PubMed Web of Science ®Google Scholar
• Abou Zahr A, Borthakur G. Emerging cell cycle inhibitors for acute myeloid leukemia. Expert Opin Emerg Drugs. 2017;22:137–148.
   PubMed Web of Science ®Google Scholar
• Tsuruda M, Yoshino H, Okamura S, et al. Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant. PLoS One. 2020;15(5):e0232545.
   PubMed Web of Science ®Google Scholar
• Wu G, Niu M, Qin J, et al. Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells. Gene. 2019;709:48–55.
   PubMed Web of Science ®Google Scholar
• Zhu X, Tian G, Quan J, et al. Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines. Int J Mol Med. 2019;44(2):643–651.
   PubMed Web of Science ®Google Scholar